12
Participants
Start Date
October 31, 2010
Primary Completion Date
October 31, 2015
Study Completion Date
May 31, 2016
Alpha 1-Antitrypsin (AAT, Aralast NP)
Eligible subjects will be treated once a week for 8 weeks (8 total treatments).
Barbara Davis Center for Childhood Diabetes, Aurora
Collaborators (1)
Omni Bio Pharmaceutical, Inc.
INDUSTRY
University of Colorado, Denver
OTHER